Author

J. Wilkinson

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Ecology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Approach:statistical model· 2 Assay:bulk RNA-seq· 1 Research Focus:chromatin & epigenetic regulation· 1 Research Focus:differential expression· 1 Assay:DNA methylation· 1 Research Focus:drug response / drug discovery· 1 Research Focus:ecology & biodiversity· 1

Frequent Co-Authors

A. Brodbelt· 1 shared A. Bruning-Richardson· 1 shared A. Chakrabarty· 1 shared A. Droop· 1 shared A. F-Bruns· 1 shared A. Gutnov· 1 shared A. Ismail· 1 shared B. Obermeyer· 1 shared

Activity by Year

2019-2020 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 22 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Brodbelt

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Site wind right: Identifying low-impact wind development areas in the Central United States

C. Hise, B. Obermeyer, M. Ahlering, J. Wilkinson, J. Fargione

The paper identifies low-impact areas for wind development in the central U.S. to support renewable energy while minimizing wildlife harm.

bioRxiv · Feb 11, 2020Ecology

JARID2 facilitates transcriptional reprogramming in glioblastoma in response to standard treatment

N. Rippaus, A. F-Bruns, G. Tanner, C. Taylor, A. Droop, A. Bruning-Richardson, M. A. Care, J. Wilkinson, M. D. Jenkinson, A. Brodbelt, A. Chakrabarty, A. Ismail, S. C. Short, L. F. Stead

The paper identifies JARID2-mediated transcriptional reprogramming in glioblastoma post-treatment, showing dysregulated genes with JARID2 binding sites are universally altered in recurrent tumors.

bioRxiv · Jun 17, 2019 · PreprintCancer Biology

Lead optimisation of dehydroemetine for repositioned use in malaria

P. Panwar, K. Burusco, M. Abubaker, H. Matthews, A. Gutnov, E. Fernandez-Alvaro, R. Bryce, J. Wilkinson, N. J. Nirmalan

This paper optimizes 2,3-dehydroemetine for repositioned use in malaria by showing its potency against P. falciparum and lack of cardiotoxicity.

bioRxiv · Feb 1, 2019Microbiology